NVCTNuvectis Pharma Inc. Common Stock
23.56USD+0.99%Mkt Cap: 767.62M $P/E: —3d ago
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NX…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap767.62M $
Enterprise Value738.62M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.44M $
Revenue/Share—
Last Price23.56 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees16
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-24.32
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B68.68
EPS (TTM)-1.32
EPS (Forward)-0.96
52W Range
5.55076% of range29.27
52W High29.27 USD
52W Low5.550 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-143.61%
ROA-83.39%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.01M $
CapEx (TTM)—
FCF Margin—
FCF Yield-1.16%
Net Debt-22.16M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.68
Quick Ratio1.67
Book Value/Sh0.3400 USD
Cash/Share0.6800 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)34.20 USD
Upside (mean)+45.2%
Target Range30.00 USD – 39.00 USD
$30.00+45.2% to mean$39.00
# Analysts5
Ownership
Shares Out.32.58M
Float21.20M
Insiders34.43%
Institutions33.55%
Short Interest
Short Ratio4.2d
Short % Float8.52%
Short % Out.5.66%
Shares Short1.84M
Short (prev mo.)1.80M
Technical
SMA 5019.03 (+23.8%)
SMA 20011.01 (+114.1%)
Beta-0.26
S&P 52W Chg18.16%
Avg Vol (30d)223.81K
Avg Vol (10d)171.84K
Technical Indicators
RSI (14)67.0
MACD0.7432
MACD Signal0.5362
MACD Hist.+0.2070
BB Upper23.26 USD
BB Middle20.23 USD
BB Lower17.19 USD
BB Width30.04%
ATR (14)1.613 USD
Vol Ratio (20d)0.92x